$8.03 +0.15 (1.904%) Amicus Therapeutics Inc - NASDAQ

Dec. 19, 2014 | 03:59 PM

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
12/04/2014Crowley John FChairman & CEO-89,000$8.36-44.93%
12/04/2014Crowley John FChairman & CEO89,000$8.3681.59%
11/25/2014Dilone EnriqueVP, Technical Operations7,000$8.0014.00%
11/25/2014Dilone EnriqueVP, Technical Operations-7,000$8.00-12.28%
11/25/2014Castelli JeffVP, Program Management8,103$8.0016.21%
11/25/2014Castelli JeffVP, Program Management-8,103$8.00-13.95%
11/25/2014Campbell Bradley LChief Operating Officer7,250$8.003.63%
11/25/2014Campbell Bradley LChief Operating Officer-7,250$8.00-3.50%
11/25/2014Baird William D IIIChief Financial Officer10,000$8.0010.00%
11/25/2014Baird William D IIIChief Financial Officer-10,000$8.00-9.09%
11/25/2014Peist KennethVP, Legal & IP-4,500$8.00-8.26%
11/25/2014Valenzano KenVP, Pharmacology & Biology-25,000$8.00-33.33%
11/25/2014Quimi DaphneVP Finance and Controller-3,500$8.00-6.54%
11/25/2014Quimi DaphneVP Finance and Controller3,500$8.007.00%
11/25/2014Peist KennethVP, Legal & IP4,500$8.009.00%
11/25/2014Valenzano KenVP, Pharmacology & Biology5,000$8.007.14%
11/25/2014Valenzano KenVP, Pharmacology & Biology10,000$8.0016.67%
11/19/2014PERCEPTIVE ADVISORS LLCSubstantial Shareholder2,100,000$6.5017.02%
10/27/2014GLAXOSMITHKLINE PLCN/A-11,315,825$5.29-100.00%
10/02/2014Castelli JeffVP, Program Management-10,208$6.01-16.95%
10/02/2014Castelli JeffVP, Program Management10,208$6.0120.42%
10/02/2014Yu JulieVP Clinical Ops & Data Mgmt-4,759$5.99-8.69%
10/02/2014Yu JulieVP Clinical Ops & Data Mgmt4,759$5.999.52%
9/29/2014Peist KennethVP, Legal & IP28,208$6.0956.42%
9/29/2014Baird William D IIIChief Financial Officer25,311$6.0925.31%
9/29/2014Peist KennethVP, Legal & IP-28,208$6.09-36.07%
9/29/2014Baird William D IIIChief Financial Officer-25,311$6.09-20.20%
9/29/2014Quimi DaphneVP Finance and Controller10,738$6.1021.48%
9/29/2014Quimi DaphneVP Finance and Controller-10,738$6.10-17.68%
8/27/2014Gershkowitz JayneVP, Patient Advocacy-5,000$7.00-9.09%
8/27/2014Gershkowitz JayneVP, Patient Advocacy5,000$7.0010.00%
8/27/2014SBLENDORIO GLENNDirector-10,000$6.50-45.59%
8/27/2014SBLENDORIO GLENNDirector10,000$6.5083.80%
8/25/2014Valenzano KenVP, Pharmacology & Biology7,450$6.0014.41%
8/25/2014Valenzano KenVP, Pharmacology & Biology5,000$6.008.45%
8/25/2014Valenzano KenVP, Pharmacology & Biology-12,450$6.00-19.41%
8/25/2014Gershkowitz JayneVP, Patient Advocacy5,000$6.0010.00%
8/25/2014Gershkowitz JayneVP, Patient Advocacy-5,000$6.00-9.09%
8/25/2014Dilone EnriqueVP, Technical Operations7,000$6.0014.00%
8/25/2014Dilone EnriqueVP, Technical Operations-7,000$6.00-12.28%
8/25/2014Campbell Bradley LChief Operating Officer7,000$6.003.50%
8/25/2014Campbell Bradley LChief Operating Officer-7,000$6.00-3.38%
8/20/2014Campbell Bradley LChief Operating Officer-18,750$5.40-8.57%
8/20/2014Campbell Bradley LChief Operating Officer18,750$5.409.38%
8/20/2014Dilone EnriqueVP, Technical Operations-12,810$5.40-20.39%
8/20/2014Dilone EnriqueVP, Technical Operations7,810$5.4014.20%
8/20/2014Dilone EnriqueVP, Technical Operations5,000$5.4010.00%
8/20/2014Gershkowitz JayneVP, Patient Advocacy-6,080$5.40-10.84%
8/20/2014Gershkowitz JayneVP, Patient Advocacy6,080$5.4012.16%
8/20/2014Valenzano KenVP, Pharmacology & Biology-7,000$5.40-11.92%
8/20/2014Valenzano KenVP, Pharmacology & Biology7,000$5.4013.54%
6/30/2014PERCEPTIVE ADVISORS LLCSubstantial Shareholder3,470,000$3.5041.61%
6/30/2014PERCEPTIVE ADVISORS LLCSubstantial Shareholder530,000$3.504.49%
6/27/2014Crowley John FChairman & CEO16,491$0.6417.81%
6/16/2014Crowley John FChairman & CEO25,000$2.6936.99%
5/12/2014Crowley John FChairman & CEO14,100$2.2226.36%
5/12/2014Crowley John FChairman & CEO900$2.211.71%
3/14/2014Do HungSr Vice President Discovery-22,065$2.26-2.17%
3/14/2014Crowley John FChairman & CEO10,000$2.2923.48%
3/12/2014Crowley John FChairman & CEO10,000$2.1630.68%
3/12/2014Do HungSr Vice President Discovery-85,032$2.21-7.72%
3/11/2014Crowley John FChairman & CEO17,108$2.21110.49%
3/11/2014Do HungSr Vice President Discovery-121,642$2.22-9.94%
3/10/2014Do HungSr Vice President Discovery-108,018$2.28-8.11%
3/07/2014Do HungSr Vice President Discovery-68,418$2.32-4.89%
12/13/2013Crowley John FChairman & CEO10,000$2.058.10%
11/25/2013Crowley John FChairman & CEO10,000$2.088.82%
11/20/2013GLAXOSMITHKLINE PLCSubstantial Shareholder1,500,000$2.0015.28%
3/15/2013Crowley John FChairman & CEO18,506$3.4919.50%
3/15/2013BARER SOL JDirector25,000$3.40125.00%
7/17/2012GLAXOSMITHKLINE PLCSubstantial Shareholder2,949,581$6.3042.96%
3/30/2012Crowley John FChairman & CEO49,931$0.64506.04%
3/07/2012BARRIS PETER JTenPercent214,846$5.7025.24%
3/07/2012BARRIS PETER JTenPercent925,154$5.7025.28%
3/07/2012KRAMLICH C RICHARDTenPercent214,846$5.7025.24%
3/07/2012NEW ENTERPRISE ASSOCIATES 11 LPTenPercent925,154$5.7025.28%
3/07/2012KRAMLICH C RICHARDTenPercent925,154$5.7025.28%
3/07/2012NEWHALL CHARLES W IIITenPercent214,846$5.7025.24%
3/07/2012PERRY MARK WTenPercent214,846$5.7025.24%
3/07/2012PERRY MARK WTenPercent925,154$5.7025.28%
3/07/2012BARRETT M JAMESSenior Executive Officer925,154$5.7025.28%
3/07/2012NEWHALL CHARLES W IIITenPercent925,154$5.7025.28%
8/11/2011Crowley John FChairman & CEO10,000$4.2010.01%
6/17/2011Crowley John FExecutive Chairman20,000$6.0425.04%
5/24/2011Valenzano KenVP, Pharmacology & Biology2,250$0.64131.73%
5/24/2011Valenzano KenVP, Pharmacology & Biology-2,250$7.50-56.85%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (FOLD), click here.
Trading Center